Otsuka Holdings Co., Ltd. (OTSKY) Stock Price & Analysis
Otsuka Holdings Co., Ltd. (OTSKY) — price $37.96 (-2.42%), as of the Nov 18, 2026 trading session; market cap $39.8B.
Educational signal · not a buy or sell recommendation · How to read this
Otsuka Holdings Co., Ltd. · OTSKY · Healthcare · Drug Manufacturers - General
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others.
Price as of Nov 18, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $37.96 | |
| Change on the day | -2.42% | |
| 52-week range | $26.11–$40.92 | |
| Market capitalisation | $39.8B | — |
| Price / earnings (trailing) | 16.66 | |
| Shares traded on the day | 2.6K | |
| Beta (volatility vs the S&P 500) | -0.05 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Otsuka Holdings Co. (OTSKY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 3 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Otsuka Holdings Co. (OTSKY), and what does it report?
Short answer
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. Healthcare / Drug Manufacturers General Headquarters: 2-9 Kanda-Tsukasamachi, Tokyo, TKY, 101-0048, JP. It employs 37,758 people and is led by Makoto Inoue. The market values it at $39.8B.
What are the financial strengths and risks for Otsuka Holdings Co. (OTSKY)?
Short answer · as of
The distress and quality screens read Altman Z 5.79 · Piotroski F 8. Trailing ratios: ROE 12.3% · ROA 9.0% · current ratio 2.28 · earnings yield 5.9% · free-cash-flow yield 4.8%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held OTSKY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported OTSKY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Otsuka Holdings Co. (OTSKY)?
OTSKY Healthcare Stock FAQ
Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
Why do Otsuka infusions matter to its business mix?
Infusions place treatment delivery alongside the company’s central nervous system, oncology, and infectious-disease medicines. They reinforce that Otsuka’s pharmaceutical activity spans therapeutic products used across distinct care settings rather than a narrow consumer-health portfolio.
What is the OTSKY stock price today?
The last price recorded for Otsuka Holdings Co., Ltd. (OTSKY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 15 figures on this page — 12 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com